167 related articles for article (PubMed ID: 30785699)
1. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
3. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
[TBL] [Abstract][Full Text] [Related]
4. Commentary on "Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer." Joh HK, Giovannucci EL, Bertrand KA, Lim S, Cho E, Department of Medicine, Seoul National University College of Medicine, Seoul, South Korea. J Natl Cancer Inst 2013; 105(10):726-32. [Epub 2013 Apr 8]. doi: 10.1093/jnci/djt082.
Boorjian S
Urol Oncol; 2014 Aug; 32(6):933-4. PubMed ID: 25087670
[TBL] [Abstract][Full Text] [Related]
5. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
7. The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma.
Xu S; Song J; Zhang ZH; Fu L; Gao L; Xie DD; Yu DX; Xu DX; Sun GP
Sci Rep; 2019 Nov; 9(1):16719. PubMed ID: 31723229
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
[TBL] [Abstract][Full Text] [Related]
10. Plasma 25-hydroxyvitamin D concentrations and risk of incident cancer in adults with hypertension: A nested case-control study.
Lin T; Song Y; Zhang X; Guo H; Liu L; Zhou Z; Wang B; Tang G; Liu C; Yang Y; Ling W; Yuan Z; Li J; Zhang Y; Huo Y; Wang X; Zhang H; Qin X; Xu X
Clin Nutr; 2019 Oct; 38(5):2381-2388. PubMed ID: 30473442
[TBL] [Abstract][Full Text] [Related]
11. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
13. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.
Southard EB; Roff A; Fortugno T; Richie JP; Kaag M; Chinchilli VM; Virtamo J; Albanes D; Weinstein S; Wilson RT
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):191-201. PubMed ID: 22086884
[TBL] [Abstract][Full Text] [Related]
14. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
[TBL] [Abstract][Full Text] [Related]
15. Circulating 25-hydroxyvitamin D3 and survival after diagnosis with kidney cancer.
Muller DC; Scelo G; Zaridze D; Janout V; Holcatova I; Navratilova M; Mates D; Midttun Ø; Ueland PM; Brennan P; Johansson M
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1277-81. PubMed ID: 26021552
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea.
Shin WK; Kim Z; Youn HJ; Cho J; Lee JE
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29558405
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
[TBL] [Abstract][Full Text] [Related]
18. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
19. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3).
Muller DC; Hodge AM; Fanidi A; Albanes D; Mai XM; Shu XO; Weinstein SJ; Larose TL; Zhang X; Han J; Stampfer MJ; Smith-Warner SA; Ma J; Gaziano JM; Sesso HD; Stevens VL; McCullough ML; Layne TM; Prentice R; Pettinger M; Thomson CA; Zheng W; Gao YT; Rothman N; Xiang YB; Cai H; Wang R; Yuan JM; Koh WP; Butler LM; Cai Q; Blot WJ; Wu J; Ueland PM; Midttun Ø; Langhammer A; Hveem K; Johansson M; Hultdin J; Grankvist K; Arslan AA; Le Marchand L; Severi G; Johansson M; Brennan P
Ann Oncol; 2018 Jun; 29(6):1468-1475. PubMed ID: 29617726
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
